PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 27 filers reported holding PROQR THRAPEUTICS N V in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,713,107 | -19.8% | 3,625,467 | 0.0% | 0.01% | -15.4% |
| Q2 2023 | $5,873,257 | -23.9% | 3,625,467 | 0.0% | 0.01% | -23.5% |
| Q1 2023 | $7,722,245 | -42.4% | 3,625,467 | 0.0% | 0.02% | -46.9% |
| Q4 2022 | $13,414,228 | +446.4% | 3,625,467 | +9.9% | 0.03% | +433.3% |
| Q3 2022 | $2,455,000 | -4.3% | 3,300,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $2,566,000 | -14.1% | 3,300,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $2,987,000 | -92.1% | 3,300,000 | -30.0% | 0.01% | -91.2% |
| Q4 2021 | $37,768,000 | -4.3% | 4,715,152 | 0.0% | 0.07% | -12.8% |
| Q3 2021 | $39,466,000 | +24.7% | 4,715,152 | +0.4% | 0.08% | +25.8% |
| Q2 2021 | $31,641,000 | +2.0% | 4,694,465 | 0.0% | 0.06% | -1.6% |
| Q1 2021 | $31,030,000 | +62.4% | 4,694,465 | +3.2% | 0.06% | +50.0% |
| Q4 2020 | $19,110,000 | -12.3% | 4,550,062 | 0.0% | 0.04% | -23.6% |
| Q3 2020 | $21,795,000 | -21.2% | 4,550,062 | 0.0% | 0.06% | -22.5% |
| Q2 2020 | $27,664,000 | +10.7% | 4,550,062 | 0.0% | 0.07% | -5.3% |
| Q1 2020 | $24,980,000 | -44.9% | 4,550,062 | -0.5% | 0.08% | -32.4% |
| Q4 2019 | $45,302,000 | +110.5% | 4,571,319 | +22.4% | 0.11% | +109.4% |
| Q3 2019 | $21,517,000 | -36.7% | 3,735,507 | 0.0% | 0.05% | -37.6% |
| Q2 2019 | $33,993,000 | -34.4% | 3,735,507 | 0.0% | 0.08% | -34.6% |
| Q1 2019 | $51,811,000 | -12.1% | 3,735,507 | 0.0% | 0.13% | -20.2% |
| Q4 2018 | $58,946,000 | -12.0% | 3,735,507 | +7.9% | 0.16% | +9.4% |
| Q3 2018 | $66,989,000 | +324.4% | 3,461,941 | +60.1% | 0.15% | +313.9% |
| Q2 2018 | $15,786,000 | +242.2% | 2,162,527 | +44.2% | 0.04% | +227.3% |
| Q1 2018 | $4,613,000 | +43.0% | 1,500,000 | +50.0% | 0.01% | +57.1% |
| Q4 2017 | $3,225,000 | – | 1,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opus Point Partners Management, LLC | 307,692 | $992,000 | 0.86% |
| DAFNA Capital Management LLC | 230,770 | $744,000 | 0.40% |
| Redmile Group, LLC | 1,558,392 | $5,026,000 | 0.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 530,000 | $1,709,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 347,245 | $1,120,000 | 0.10% |
| Artal Group S.A. | 1,900,000 | $6,128,000 | 0.09% |
| Genovese Burford & Brothers Wealth & Retirement Plan Management, LLC | 7,500 | $24,000 | 0.06% |
| Orbimed Advisors | 1,302,955 | $4,202,000 | 0.05% |
| ALTRINSIC GLOBAL ADVISORS LLC | 191,360 | $617,000 | 0.02% |
| JENNISON ASSOCIATES LLC | 2,635,552 | $8,500,000 | 0.01% |